| Dr Marc Edward Walker, MD, MBA | |
|
2500 N State St, Jackson, MS 39216-4500 | |
| (601) 984-1000 | |
| Not Available |
| Full Name | Dr Marc Edward Walker |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 13 Years |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245598325 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2082S0105X | Plastic Surgery - Surgery Of The Hand | 26701 (Mississippi) | Secondary |
| 208200000X | Plastic Surgery | 26701 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Mississippi Med Center | Jackson, MS | Hospital |
| Merit Health Madison | Canton, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Mississippi - University Of Mississippi Medical Center | 1850293036 | 804 |
News Archive
An ever-growing number of coatings, including varnishes and printing inks, as well as tooth fillings, are cured with light.
A collaborative team of investigators at the Medical University of South Carolina and Loyola University have demonstrated for the first time that culturing T cells in N-acetyl cysteine (NAC) before they are infused as immunotherapy improves effectiveness and outcomes in a preclinical model of melanoma. These findings were reported in the October 15, 2016 issue of Cancer Research.
TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections (SSIs) associated with cardiovascular implantable electronic devices (CIEDs), announced today that the 1000th patient has been enrolled into the CITADEL & CENTURION clinical studies evaluating the company's AIGISRx Antibacterial Envelope.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications announced that its Healthcare Division, Spacelabs Healthcare, has been awarded a one-year $13.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Defense Supply Center Philadelphia Medical Supplier Operations Directorate to provide patient monitoring systems, sub-systems, training and consumables.
A study published in the September issue of Cancer Cell provides new evidence for a genetic pathway that is involved in the recurrence of breast cancer and identifies a potential target for development of new anticancer therapeutics.
› Verified 3 days ago
| Entity Name | Joseph M Still Burn Centers, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215904909 PECOS PAC ID: 7618963638 Enrollment ID: O20080305000222 |
News Archive
An ever-growing number of coatings, including varnishes and printing inks, as well as tooth fillings, are cured with light.
A collaborative team of investigators at the Medical University of South Carolina and Loyola University have demonstrated for the first time that culturing T cells in N-acetyl cysteine (NAC) before they are infused as immunotherapy improves effectiveness and outcomes in a preclinical model of melanoma. These findings were reported in the October 15, 2016 issue of Cancer Research.
TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections (SSIs) associated with cardiovascular implantable electronic devices (CIEDs), announced today that the 1000th patient has been enrolled into the CITADEL & CENTURION clinical studies evaluating the company's AIGISRx Antibacterial Envelope.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications announced that its Healthcare Division, Spacelabs Healthcare, has been awarded a one-year $13.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Defense Supply Center Philadelphia Medical Supplier Operations Directorate to provide patient monitoring systems, sub-systems, training and consumables.
A study published in the September issue of Cancer Cell provides new evidence for a genetic pathway that is involved in the recurrence of breast cancer and identifies a potential target for development of new anticancer therapeutics.
› Verified 3 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
An ever-growing number of coatings, including varnishes and printing inks, as well as tooth fillings, are cured with light.
A collaborative team of investigators at the Medical University of South Carolina and Loyola University have demonstrated for the first time that culturing T cells in N-acetyl cysteine (NAC) before they are infused as immunotherapy improves effectiveness and outcomes in a preclinical model of melanoma. These findings were reported in the October 15, 2016 issue of Cancer Research.
TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections (SSIs) associated with cardiovascular implantable electronic devices (CIEDs), announced today that the 1000th patient has been enrolled into the CITADEL & CENTURION clinical studies evaluating the company's AIGISRx Antibacterial Envelope.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications announced that its Healthcare Division, Spacelabs Healthcare, has been awarded a one-year $13.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Defense Supply Center Philadelphia Medical Supplier Operations Directorate to provide patient monitoring systems, sub-systems, training and consumables.
A study published in the September issue of Cancer Cell provides new evidence for a genetic pathway that is involved in the recurrence of breast cancer and identifies a potential target for development of new anticancer therapeutics.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marc Edward Walker, MD, MBA 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-1000 | Dr Marc Edward Walker, MD, MBA 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-1000 |
News Archive
An ever-growing number of coatings, including varnishes and printing inks, as well as tooth fillings, are cured with light.
A collaborative team of investigators at the Medical University of South Carolina and Loyola University have demonstrated for the first time that culturing T cells in N-acetyl cysteine (NAC) before they are infused as immunotherapy improves effectiveness and outcomes in a preclinical model of melanoma. These findings were reported in the October 15, 2016 issue of Cancer Research.
TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections (SSIs) associated with cardiovascular implantable electronic devices (CIEDs), announced today that the 1000th patient has been enrolled into the CITADEL & CENTURION clinical studies evaluating the company's AIGISRx Antibacterial Envelope.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications announced that its Healthcare Division, Spacelabs Healthcare, has been awarded a one-year $13.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Defense Supply Center Philadelphia Medical Supplier Operations Directorate to provide patient monitoring systems, sub-systems, training and consumables.
A study published in the September issue of Cancer Cell provides new evidence for a genetic pathway that is involved in the recurrence of breast cancer and identifies a potential target for development of new anticancer therapeutics.
› Verified 3 days ago
Dr. Fred Blackledge, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 764 Lakeland Dr, Jackson, MS 39216 Phone: 601-981-3033 Fax: 601-982-8132 | |
Mrs. Marie Yonko, RN, BSN, CNOR, RNFA Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Div. Of Plastic Surgery, Jackson, MS 39216 Phone: 601-984-5180 Fax: 601-984-5183 | |
Dr. Michael Thomas Friel, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2500 N State St, Division Of Plastic Surgery, Jackson, MS 39216 Phone: 601-984-5180 Fax: 601-984-5183 | |
Benjamin C. Mcintyre, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Dept Of Surgery, Jackson, MS 39216 Phone: 601-984-5452 Fax: 601-815-3322 | |
Marcus D Walkinshaw, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5180 | |
Phillip Blevins, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5180 Fax: 601-984-5183 |